Medstry Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.99 M
- Paid Up Capital ₹ 4.97 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
About Medstry Biotech
Medstry Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2019 (Five years and eight months 8 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.99 M and a paid-up capital of Rs 4.97 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Talwar, Deepika Khandooja, Bindu Sood, and One other member serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239CH2019PTC042546
-
Company No.
042546
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 May 2019
-
Date of AGM
31 Mar 2022
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Medstry Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Talwar
|
Director | 01-Aug-2021 | Current |
|
Deepika Khandooja
|
Director | 01-Aug-2021 | Current |
|
Bindu Sood
|
Director | 27-May-2019 | Current |
|
Sonal Pahwa
|
Director | 01-Aug-2021 | Current |
Financial Performance of Medstry Biotech.
Medstry Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medstry Biotech?
In 2020, Medstry Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Orioles Healthconnect Private LimitedSumit Talwar and Sonal Pahwa are mutual person
-
Orioles Health India Private Limited
Sumit Talwar and Sonal Pahwa are mutual person
-
Inter Globe Health Services India Private Limited
Sumit Talwar and Sonal Pahwa are mutual person
-
Asl Medical Private Limited
Sumit Talwar and Sonal Pahwa are mutual person
-
Stan's Kitchen Llp
Sumit Talwar is a mutual person
-
Grokap Healthcare Private Limited
Deepika Khandooja is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medstry Biotech?
Medstry Biotech has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medstry Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medstry Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
